Activist 13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...17, 18, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-06-10
5:01 pm
Purchase
13GCelcuity Inc.
CELC
BIOTECHNOLOGY VALUE FUND L P3,466,000
9.9%
3,466,000increase
(New Position)
View
2024-05-30
4:51 pm
Purchase
13GFoghorn Therapeutics Inc.
FHTX
BIOTECHNOLOGY VALUE FUND L P5,552,341
9.99%
5,552,341increase
(New Position)
View
2024-05-17
5:07 pm
Unchanged
13GPIERIS PHARMACEUTICALS INC
PIRS
BIOTECHNOLOGY VALUE FUND L P257,622
19.5%
0
(Unchanged)
View
2024-05-17
5:07 pm
Purchase
13GPIERIS PHARMACEUTICALS INC
PIRS
BIOTECHNOLOGY VALUE FUND L P257,622
19.5%
257,622increase
(New Position)
View
2024-03-05
4:59 pm
Unchanged
13DMoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P21,751,284
34.6%
0
(Unchanged)
View
2024-02-22
4:45 pm
Unchanged
13GenGene Holdings Inc.
ENGN
BIOTECHNOLOGY VALUE FUND L P3,196,439
7.2%
0
(Unchanged)
View
2024-02-14
10:30 am
Sale
13GAclaris Therapeutics Inc.
ACRS
BIOTECHNOLOGY VALUE FUND L P0
0%
-3,360,941decrease
(Position Closed)
View
2024-02-14
10:28 am
Sale
13GAileron Therapeutics Inc.
ALRN
BIOTECHNOLOGY VALUE FUND L P0
0%
-236,835decrease
(Position Closed)
View
2024-02-14
10:26 am
Purchase
13GAnnexon Inc.
ANNX
BIOTECHNOLOGY VALUE FUND L P7,000,000
8.9%
3,219,306increase
(+85.15%)
View
2024-02-14
10:24 am
Purchase
13GAravive Inc.
ARAV
BIOTECHNOLOGY VALUE FUND L P8,164,510
9.99%
2,055,452increase
(+33.65%)
View
2024-02-14
10:22 am
Purchase
13GASLAN PHARMACEUTICALS LTD SPON
ASLN
BIOTECHNOLOGY VALUE FUND L P43,344,975
9.99%
43,344,975increase
(New Position)
View
2024-02-14
10:20 am
Sale
13GBIONOMICS LIMITED
BNOX
BIOTECHNOLOGY VALUE FUND L P0
0%
-170,089,885decrease
(Position Closed)
View
2024-02-14
10:18 am
Purchase
13GCidara Therapeutics Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P9,275,527
9.99%
2,414,400increase
(+35.19%)
View
2024-02-14
10:16 am
Sale
13GCullinan Therapeutics Inc.
CGEM
BIOTECHNOLOGY VALUE FUND L P4,393,321
9.99%
-3,115,738decrease
(-41.49%)
View
2024-02-14
10:13 am
Purchase
13GCentessa Pharmaceuticals plc
CNTA
BIOTECHNOLOGY VALUE FUND L P8,774,570
9%
1,880,225increase
(+27.27%)
View
2024-02-14
10:11 am
Sale
13GCrinetics Pharmaceuticals Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P0
0%
-2,736,613decrease
(Position Closed)
View
2024-02-14
10:09 am
Purchase
13GCytomX Therapeutics Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P6,702,889
9.99%
107,088increase
(+1.62%)
View
2024-02-14
10:08 am
Purchase
13GDELCATH SYS INC
DCTH
BIOTECHNOLOGY VALUE FUND L P2,338,426
9.99%
776,912increase
(+49.75%)
View
2024-02-14
10:06 am
Purchase
13GEledon Pharmaceuticals Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P4,326,710
17.9%
2,000,000increase
(+85.96%)
View
2024-02-14
10:01 am
Purchase
13GElevation Oncology Inc.
ELEV
BIOTECHNOLOGY VALUE FUND L P4,450,885
9.99%
2,138,685increase
(+92.50%)
View
Goto 0, 1, 2, ...17, 18, Next